We use cookies to ensure that our site works correctly and provides you with the best experience. If you continue using our site without changing your browser settings, we'll assume that you agree to our use of cookies. Find out more about the cookies we use and how to manage them by reading our cookies policy.
Many broad-based drugs are effective in only 30-60% of those treated with them. Increasingly, clinicians are trying to move away from this one-size-fits-all approach and offer more personalised treatments and care tailored to individuals.